Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in phase I study of BJ-001 in advanced or metastatic solid tumors

Dec. 10, 2019

InMed receives CTA approval for phase I study of INM-755

Dec. 10, 2019

Phase II data presented for KVD-001 in patients with diabetic macular edema

Dec. 10, 2019

Once-a-month oral contraceptive

Dec. 10, 2019

Cantargia announces start of CAN-10 development project for systemic sclerosis and myocarditis

Dec. 10, 2019

Phase III study of nadofaragene firadenovec in bladder cancer meets primary endpoint

Dec. 9, 2019

Partial clinical hold for pediatric patients in Ipsen's FOP and MO studies of palovarotene

Dec. 9, 2019

Phase III PRIMROSE 2 trial of linzagolix for heavy menstrual bleeding meets endpoints

Dec. 9, 2019

Phase III BE SURE study of bimekizumab in plaque psoriasis meets coprimary endpoints

Dec. 9, 2019

New phase II trial investigates OQL-011 for hand-foot skin reaction in cancer patients

Dec. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...